Amicus Establishes Global Research and Gene Therapy Center of Excellence in Philadelphia

CRANBURY, N.J. and PHILADELPHIA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics today announced it is establishing a new Global Research and Gene Therapy Center of Excellence in uCity Square in Philadelphia, PA, to advance its commitment to world-class science that makes a meaningful difference in the lives of people living with rare metabolic diseases.

Previous
Previous

Rare As One: Leveraging the Power of Patients to Accelerate Rare Disease Research

Next
Next

Could Statins Ease Deadly Heart Condition in Rare Neuromuscular Disease?